Pesticides & Agrochemicals · Founded 2015 · www.dharmajcrop.com · BSE 543687 · NSE DHARMAJ · ISIN INE00OQ01016
No Notes Added Yet
Business
Dharmaj Crop Guard Ltd. is an agrochemical company primarily engaged in the manufacturing, formulating, and marketing of a diverse range of crop protection products. Its product portfolio includes insecticides, fungicides, herbicides, plant growth regulators, micro-fertilizers, and antibiotics. The company caters to farmers across India through an extensive distribution network, helping them protect crops and improve yields. It operates on a B2C model (selling formulations to farmers via distributors) and also undertakes institutional sales and contract manufacturing. The core business model involves developing, registering, and distributing a wide array of agrochemical formulations tailored to different crops and pests.
Revenue Mix
Dharmaj Crop Guard's revenue is primarily derived from the sale of its agrochemical formulations. While specific segment-wise revenue percentages are not always disaggregated publicly beyond broad categories, the major product types contributing include:
Insecticides: Products designed to control insect pests.
Fungicides: Products used to control fungal diseases in crops.
Herbicides: Products for weed control.
Plant Growth Regulators (PGRs) & Micro-fertilizers: Products that enhance crop growth and nutrient uptake.
The company has a significant domestic market presence through its distribution network and also engages in exports to various countries.
Industry
The Indian Pesticides & Agrochemicals industry is one of the largest globally, driven by the country's vast agricultural sector. It is characterized by a mix of large multinational corporations and numerous domestic players. The industry is sensitive to monsoon patterns, government policies, and global raw material prices. Dharmaj Crop Guard is positioned as a mid-sized domestic player, focusing on a wide product portfolio and an extensive distribution network, particularly in key agricultural states of India. It competes by offering a range of effective and affordable crop protection solutions, aiming to capture market share from both organized and unorganized segments.
MOAT
Dharmaj Crop Guard possesses developing competitive advantages:
Extensive Distribution Network: A wide and deep reach into rural Indian markets through a multi-tier distribution system is a significant barrier to entry and a key asset in reaching farmers.
Diversified Product Portfolio: Offering a broad range of products across different categories (insecticides, fungicides, herbicides, PGRs) reduces dependence on a single product or crop, providing resilience.
Product Registration & Development: Continuous efforts in obtaining new product registrations and developing new formulations enhance its market offerings and intellectual property.
Cost-Effective Manufacturing: Leveraging local manufacturing capabilities to offer competitive pricing.
Growth Drivers
Increasing Food Demand: Growing population and increasing per capita consumption drive demand for higher agricultural output, necessitating crop protection.
Awareness & Adoption: Increasing awareness among farmers about the benefits of quality agrochemicals for yield enhancement and pest control.
New Product Launches & Registrations: Continuous introduction of new and effective formulations and obtaining necessary regulatory registrations expands market opportunities.
Expansion of Distribution Network: Further penetration into untapped agricultural regions within India and potential expansion into new export markets.
Government Support: Initiatives to boost agricultural productivity and farmer income can indirectly support agrochemical demand.
Risks
Monsoon Dependency: The performance of the agricultural sector, and consequently agrochemical sales, is heavily reliant on timely and adequate monsoons.
Raw Material Price Volatility: Fluctuations in the prices of key raw materials and intermediates can impact manufacturing costs and profitability.
Regulatory Changes: Changes in government policies regarding agrochemical use, environmental regulations, or bans on specific molecules can significantly affect operations.
Intense Competition: The presence of numerous domestic and international players leads to pricing pressure and market share battles.
Pest Resistance: Continuous use of certain agrochemicals can lead to pest resistance, requiring constant R&D for new solutions.
Environmental & Health Concerns: Growing scrutiny over the environmental and health impact of pesticides can lead to tighter regulations and consumer aversion.
Management & Ownership
Dharmaj Crop Guard is a promoter-driven company. The management team, led by its founders, brings significant experience and expertise in the agrochemical industry, particularly in product development, manufacturing, and marketing within the Indian context. As of recent data, the promoter group holds a substantial majority stake in the company, aligning their interests with long-term growth. The company became publicly listed relatively recently (late 2022), indicating a move towards greater transparency and corporate governance standards.
Outlook
Dharmaj Crop Guard is positioned to benefit from the fundamental demand for food security and improving agricultural productivity in India. Its established distribution network, diverse product portfolio, and focus on new registrations provide a strong foundation for future growth. The company's strategy to expand its market reach and introduce new products aligns with the increasing adoption of crop protection solutions by farmers. However, its performance remains susceptible to the inherent volatility of the agriculture sector, including monsoon dependency, fluctuations in raw material costs, and evolving regulatory landscapes. Intense competition and the continuous need for R&D to counter pest resistance are also ongoing challenges that could impact profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 116 | 255 | 311 | 175 | 210 | 367 | 347 | 190 |
| Other Income | 0 | 0 | 0 | -0 | 2 | 1 | 0 | 3 |
| Total Income | 116 | 256 | 312 | 174 | 211 | 368 | 347 | 193 |
| Total Expenditure | 116 | 228 | 277 | 165 | 206 | 317 | 315 | 182 |
| Operating Profit | 0 | 27 | 35 | 9 | 5 | 52 | 32 | 10 |
| Interest | 2 | 3 | 3 | 3 | 4 | 3 | 5 | 5 |
| Depreciation | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | 20 | 27 | 2 | -3 | 44 | 23 | 1 |
| Provision for Tax | -2 | 5 | 6 | 0 | -1 | 11 | 5 | 0 |
| Profit After Tax | -3 | 15 | 21 | 1 | -2 | 33 | 17 | 1 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -3 | 15 | 21 | 1 | -2 | 33 | 17 | 1 |
| Adjusted Earnings Per Share | -1 | 4.5 | 6.2 | 0.3 | -0.7 | 9.6 | 5.1 | 0.2 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 654 | 951 | 1114 |
| Other Income | 3 | 2 | 6 |
| Total Income | 658 | 953 | 1119 |
| Total Expenditure | 591 | 876 | 1020 |
| Operating Profit | 66 | 77 | 99 |
| Interest | 3 | 13 | 17 |
| Depreciation | 5 | 18 | 20 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 57 | 46 | 65 |
| Provision for Tax | 13 | 11 | 15 |
| Profit After Tax | 44 | 35 | 49 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 44 | 35 | 49 |
| Adjusted Earnings Per Share | 13.1 | 10.3 | 14.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 45% | 0% | 0% | 0% |
| Operating Profit CAGR | 17% | 0% | 0% | 0% |
| PAT CAGR | -20% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 26% | 20% | NA% | NA% |
| ROE Average | 9% | 11% | 11% | 11% |
| ROCE Average | 12% | 12% | 12% | 12% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 359 | 394 |
| Minority's Interest | 0 | 0 |
| Borrowings | 76 | 64 |
| Other Non-Current Liabilities | 2 | 6 |
| Total Current Liabilities | 126 | 269 |
| Total Liabilities | 563 | 733 |
| Fixed Assets | 312 | 311 |
| Other Non-Current Assets | 6 | 12 |
| Total Current Assets | 244 | 411 |
| Total Assets | 563 | 733 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 3 |
| Cash Flow from Operating Activities | 7 | 39 |
| Cash Flow from Investing Activities | -62 | -33 |
| Cash Flow from Financing Activities | 57 | -9 |
| Net Cash Inflow / Outflow | 3 | -3 |
| Closing Cash & Cash Equivalent | 3 | 0 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 13.13 | 10.3 |
| CEPS(Rs) | 14.74 | 15.71 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 106.33 | 116.7 |
| Core EBITDA Margin(%) | 9.29 | 7.61 |
| EBIT Margin(%) | 8.99 | 5.97 |
| Pre Tax Margin(%) | 8.48 | 4.66 |
| PAT Margin (%) | 6.55 | 3.54 |
| Cash Profit Margin (%) | 7.35 | 5.4 |
| ROA(%) | 7.88 | 5.37 |
| ROE(%) | 12.35 | 9.24 |
| ROCE(%) | 12.93 | 11.96 |
| Receivable days | 63.93 | 68.17 |
| Inventory Days | 50.3 | 43.06 |
| Payable days | 47.4 | 64.5 |
| PER(x) | 17 | 17.58 |
| Price/Book(x) | 2.1 | 1.55 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 1.32 | 0.76 |
| EV/Core EBITDA(x) | 13.01 | 9.42 |
| Net Sales Growth(%) | 0 | 45.4 |
| EBIT Growth(%) | 0 | -3.74 |
| PAT Growth(%) | 0 | -21.52 |
| EPS Growth(%) | 0 | -21.52 |
| Debt/Equity(x) | 0.31 | 0.29 |
| Current Ratio(x) | 1.94 | 1.53 |
| Quick Ratio(x) | 1.2 | 1.02 |
| Interest Cover(x) | 17.69 | 4.55 |
| Total Debt/Mcap(x) | 0.15 | 0.19 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 |
| FII | 4.35 | 5.5 | 6.97 | 4.4 | 3.77 | 4.14 | 3.58 | 3.09 | 3.49 | 3.13 |
| DII | 0 | 0.14 | 0.14 | 0.14 | 0.43 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.25 | 23.95 | 22.48 | 25.05 | 25.4 | 25.46 | 26.02 | 26.51 | 26.11 | 26.47 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 |
| FII | 0.15 | 0.19 | 0.24 | 0.15 | 0.13 | 0.14 | 0.12 | 0.1 | 0.12 | 0.11 |
| DII | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.85 | 0.81 | 0.76 | 0.85 | 0.86 | 0.86 | 0.88 | 0.9 | 0.88 | 0.89 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +45% | — | — | — |
| Operating Profit CAGR | +17% | — | — | — |
| PAT CAGR | -20% | — | — | — |
| Share Price CAGR | +26% | +20% | — | — |
| ROE Average | +9% | +11% | +11% | +11% |
| ROCE Average | +12% | +12% | +12% | +12% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 | 70.4 |
| FII | 4.35 | 5.5 | 6.97 | 4.4 | 3.77 | 4.14 | 3.58 | 3.09 | 3.49 | 3.13 |
| DII | 0 | 0.14 | 0.14 | 0.14 | 0.43 | 0 | 0 | 0 | 0 | 0 |
| Public | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 | 29.6 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 | 2.38 |
| FII | 0.15 | 0.19 | 0.24 | 0.15 | 0.13 | 0.14 | 0.12 | 0.1 | 0.12 | 0.11 |
| DII | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Public | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.